ATAI Life Sciences joined the mental health market in 2018 but is already working on various compounds for depression, anxiety, addiction, etc. Their research is based on psychedelics, but they are now also involved in the digital health space. IntroSpect is a digital platform of ATAI Life Sciences where they leverage flexibility and technology to meet their patient’s requirements.
